FDA approves Gilead's Truvada as first pill for HIV prevention

Gilead Sciences Inc.'s HIV-fighting pill Truvada was approved Monday to prevent transmission of the AIDS virus.

It is the first agent to be approved for HIV prevention in uninfected adults, said Foster City-based Gilead (NASDAQ: GILD).